{"id":191082,"date":"2026-08-07T16:19:12","date_gmt":"2026-08-07T10:49:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=191082"},"modified":"2026-08-07T16:19:15","modified_gmt":"2026-08-07T10:49:15","slug":"medplus-health-services-share-price-target-2027-2028-2030","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/","title":{"rendered":"Medplus Health Services Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast"},"content":{"rendered":"<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>CMP Rs 806.95. FY26 EPS Rs 18.3; 16% annual growth. Target 2027: Rs 835 (+3%). Target 2028: Rs 1,000. Target 2030: Rs 1,440 (+78%).<\/em><\/p>\n<p>Medplus Health Services at Rs 806.95 is the second-largest pharmacy chain in India after PharmEasy and Reliance Retail Pharma, operating a hyper-clustered store footprint concentrated in Telangana, Andhra Pradesh, Tamil Nadu, and Karnataka. This geographic concentration is both Medplus&#8217;s strength (deep market penetration with competitive cluster effects) and its primary risk (limited revenue from North and West India). The Medplus Health Services share price target of Rs 835 for 2027, rising to Rs 1,440 by 2030, reflects steady South India pharmacy expansion plus a cautious view on North India replication speed.<\/p>\n<p>The Medplus Health Services share price target of Rs 835 for 2027, rising to Rs 1,440 by 2030, reflects 16% annual earnings growth with a forward multiple consistent with Pharmacy Retail peers. This article covers the Medplus Health Services share price target 2027, 2028, and 2030 based on FY26 financials and analyst estimates as of August 2026.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=medplus-health-services-tgt\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Medplus_Health_Services_Company_Overview\" title=\"Medplus Health Services Company Overview\">Medplus Health Services Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Why_Is_the_Medplus_Health_Services_Share_Price_Target_Set_at_Rs_835_for_2027\" title=\"Why Is the Medplus Health Services Share Price Target Set at Rs 835 for 2027\">Why Is the Medplus Health Services Share Price Target Set at Rs 835 for 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#South_India_Cluster_Model_Creates_Last-Mile_Pharmacy_Dominance\" title=\"South India Cluster Model Creates Last-Mile Pharmacy Dominance\">South India Cluster Model Creates Last-Mile Pharmacy Dominance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Generic_Drug_Substitution_Push_by_Government_Benefits_Pharmacy_Chains\" title=\"Generic Drug Substitution Push by Government Benefits Pharmacy Chains\">Generic Drug Substitution Push by Government Benefits Pharmacy Chains<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Own-Brand_Generics_Provide_Higher_Margin_Revenue_Versus_Branded_Drugs\" title=\"Own-Brand Generics Provide Higher Margin Revenue Versus Branded Drugs\">Own-Brand Generics Provide Higher Margin Revenue Versus Branded Drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Health_and_Wellness_Adjacent_Products_Expand_Revenue_Per_Customer\" title=\"Health and Wellness Adjacent Products Expand Revenue Per Customer\">Health and Wellness Adjacent Products Expand Revenue Per Customer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Digital_Prescription_Integration_and_Telehealth_Partnership_Potential_Is_Significant\" title=\"Digital Prescription Integration and Telehealth Partnership Potential Is Significant\">Digital Prescription Integration and Telehealth Partnership Potential Is Significant<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Medplus_Health_Services_Share_Price_Targets_2027_2028_and_2030\" title=\"Medplus Health Services Share Price Targets 2027, 2028 and 2030\">Medplus Health Services Share Price Targets 2027, 2028 and 2030<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Medplus_Health_Services_Share_Price_Target_2027_Rs_835\" title=\"Medplus Health Services Share Price Target 2027: Rs 835\">Medplus Health Services Share Price Target 2027: Rs 835<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Medplus_Health_Services_Share_Price_Target_2028_Rs_1000\" title=\"Medplus Health Services Share Price Target 2028: Rs 1,000\">Medplus Health Services Share Price Target 2028: Rs 1,000<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Medplus_Health_Services_Share_Price_Target_2030_Rs_1440\" title=\"Medplus Health Services Share Price Target 2030: Rs 1,440\">Medplus Health Services Share Price Target 2030: Rs 1,440<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Bull_Case_and_Bear_Case_for_the_Medplus_Health_Services_Share_Price_Target_2030\" title=\"Bull Case and Bear Case for the Medplus Health Services Share Price Target 2030\">Bull Case and Bear Case for the Medplus Health Services Share Price Target 2030<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Bull_Case_Rs_1843\" title=\"Bull Case: Rs 1,843\">Bull Case: Rs 1,843<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Bear_Case_Rs_1094\" title=\"Bear Case: Rs 1,094\">Bear Case: Rs 1,094<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Key_Risks_to_the_Medplus_Health_Services_Share_Price_Target\" title=\"Key Risks to the Medplus Health Services Share Price Target\">Key Risks to the Medplus Health Services Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#USFDA_Inspection_and_Compliance_Risk\" title=\"USFDA Inspection and Compliance Risk\">USFDA Inspection and Compliance Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Currency_Risk_on_Export_Revenue\" title=\"Currency Risk on Export Revenue\">Currency Risk on Export Revenue<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Pricing_Pressure_in_Regulated_Generic_Markets\" title=\"Pricing Pressure in Regulated Generic Markets\">Pricing Pressure in Regulated Generic Markets<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Clinical_Trial_and_Pipeline_Risk\" title=\"Clinical Trial and Pipeline Risk\">Clinical Trial and Pipeline Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#How_to_Invest_in_Medplus_Health_Services\" title=\"How to Invest in Medplus Health Services\">How to Invest in Medplus Health Services<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Frequently_Asked_Questions_on_Medplus_Health_Services_Share_Price_Target_2027_2028_and_2030\" title=\"Frequently Asked Questions on Medplus Health Services Share Price Target 2027 2028 and 2030\">Frequently Asked Questions on Medplus Health Services Share Price Target 2027 2028 and 2030<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#What_is_the_Medplus_Health_Services_share_price_target_for_2027\" title=\"What is the Medplus Health Services share price target for 2027?\">What is the Medplus Health Services share price target for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#What_is_the_Medplus_Health_Services_share_price_target_for_2030\" title=\"What is the Medplus Health Services share price target for 2030?\">What is the Medplus Health Services share price target for 2030?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#Is_Medplus_Health_Services_a_good_long-term_investment\" title=\"Is Medplus Health Services a good long-term investment?\">Is Medplus Health Services a good long-term investment?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#What_do_most_investors_miss_about_Medplus_Health_Services\" title=\"What do most investors miss about Medplus Health Services?\">What do most investors miss about Medplus Health Services?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#What_is_the_bull_case_for_the_Medplus_Health_Services_share_price_target_2030\" title=\"What is the bull case for the Medplus Health Services share price target 2030?\">What is the bull case for the Medplus Health Services share price target 2030?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#What_are_the_main_risks_to_the_Medplus_Health_Services_share_price_target\" title=\"What are the main risks to the Medplus Health Services share price target?\">What are the main risks to the Medplus Health Services share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#What_is_Medplus_Health_Servicess_52-week_high_and_low_share_price\" title=\"What is Medplus Health Services&#8217;s 52-week high and low share price?\">What is Medplus Health Services&#8217;s 52-week high and low share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/medplus-health-services-share-price-target-2027-2028-2030\/#How_can_I_buy_Medplus_Health_Services_shares\" title=\"How can I buy Medplus Health Services shares?\">How can I buy Medplus Health Services shares?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Medplus_Health_Services_Company_Overview\"><\/span><strong>Medplus Health Services Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse: collapse; width: 100%; margin: 16px 0;\">\n<tbody>\n<tr style=\"background: #1F4E79; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; border: 1px solid #ddd;\">Metric<\/th>\n<th style=\"padding: 8px 12px; text-align: left; border: 1px solid #ddd;\">Details<\/th>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">NSE Ticker<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\"><a href=\"https:\/\/univest.in\/stocks\/medplus\/medplus-health-services-ltd-share-price-today\">MEDPLUS<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Sector<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Pharmacy Retail<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">CMP (07 Aug 2026)<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 806.95<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">52-Week High<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 1,200<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">52-Week Low<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 680<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Market Cap<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 9,928 Cr<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">FY26 EPS<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 18.3 (16% annual growth)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Promoter Holding<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">47%<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">12M Consensus<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">\u20b91,100 (+36%)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Medplus Health Services Share Price Target 2027<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 835 (+3%)<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Medplus Health Services Share Price Target 2028<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 1,000 (+24%)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Medplus Health Services Share Price Target 2030<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 1,440 (+78%)<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Bull Case 2030<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 1,843<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Bear Case 2030<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 1,094<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"border-left: 4px solid #e67e22; background: #FEF9F0; padding: 10px 16px;\"><strong>What most investors miss:<\/strong> MedPlus runs a hyper-clustered, largely South India store footprint. A large share of stores operate on a cluster model where proximity to each other improves last-mile fulfilment and customer stickiness. The South India pharmacy market is more organised and brand-conscious than North India, giving MedPlus a stronger competitive position in its home markets. The risk: pan-India expansion requires building similar cluster density in new markets, which is capital-intensive and time-consuming.<\/p>\n<p>Assuming approximately20% annual earnings growth off a FY26 base EPS of \u20b918. 3 and a fair multiple of approximately38x (moderating to approximately16% growth long-term), the stock&#8217;s valuation trend points to the figures above. The share price targets of Rs 835 for 2027, Rs 1,000 for 2028, and Rs 1,440 for 2030 are derived from this earnings trajectory and peer multiples.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Medplus_Health_Services_Share_Price_Target_Set_at_Rs_835_for_2027\"><\/span><strong>Why Is the Medplus Health Services Share Price Target Set at Rs 835 for 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"South_India_Cluster_Model_Creates_Last-Mile_Pharmacy_Dominance\"><\/span><strong>South India Cluster Model Creates Last-Mile Pharmacy Dominance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This is the foundational driver of the Medplus Health Services share price target of Rs 835 for 2027 and Rs 1,440 by 2030. Assuming approximately20% annual earnings growth off a FY26 base EPS of \u20b918.3 and a fair multiple of approximately38x (moderating to approximately16% growth long-term), the stock&#8217;s valuation trend poi. The market will progressively price this as quarterly data confirms the trajectory.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Generic_Drug_Substitution_Push_by_Government_Benefits_Pharmacy_Chains\"><\/span><strong>Generic Drug Substitution Push by Government Benefits Pharmacy Chains<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Investors analysing the Medplus Health Services share price target should track this dimension quarterly, as it provides the clearest signal of whether the compounding thesis is on track. Evidence of sustained improvement in this area is the primary re-rating catalyst for the Medplus Health Services share price target 2028 of Rs 911.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Own-Brand_Generics_Provide_Higher_Margin_Revenue_Versus_Branded_Drugs\"><\/span><strong>Own-Brand Generics Provide Higher Margin Revenue Versus Branded Drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This structural factor is often underweighted in standard Medplus Health Services share price target analyses, which focus on trailing earnings multiples rather than the competitive positioning embedded in the long-term franchise value. Its persistence through economic cycles is what differentiates the Medplus Health Services share price target 2030 case from a short-term trading call.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Health_and_Wellness_Adjacent_Products_Expand_Revenue_Per_Customer\"><\/span><strong>Health and Wellness Adjacent Products Expand Revenue Per Customer<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>For the Medplus Health Services share price target of Rs 1,440 to materialise by 2030, this factor needs to remain intact and compound over 4 years. Quarterly updates on this metric provide the earliest warning signal of any deviation from the Medplus Health Services share price target base case assumptions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Digital_Prescription_Integration_and_Telehealth_Partnership_Potential_Is_Significant\"><\/span><strong>Digital Prescription Integration and Telehealth Partnership Potential Is Significant<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As India&#8217;s economy compounds through 2027 to 2030, this factor provides an additional secular tailwind that is layered on top of the Medplus Health Services-specific earnings growth already embedded in the Rs 835 target for 2027 and the Rs 1,440 target for 2030.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Medplus_Health_Services_Share_Price_Targets_2027_2028_and_2030\"><\/span><strong>Medplus Health Services Share Price Targets 2027, 2028 and 2030<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Medplus_Health_Services_Share_Price_Target_2027_Rs_835\"><\/span><strong>Medplus Health Services Share Price Target 2027: Rs 835<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Medplus Health Services share price target 2027 is Rs 835, representing approximately 3 percent upside from CMP Rs 806.95. Assuming approximately20% annual earnings growth off a FY26 base EPS of \u20b918.3 and a fair multiple of approximately38x (moderating to approximately16% growth long-term), the stock&#8217;s valuation trend points to the figures above. Street consensus (1-yr). By 2027, the key catalyst for achieving this level is validation of the earnings trajectory through 2 consecutive quarters of on-target performance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Medplus_Health_Services_Share_Price_Target_2028_Rs_1000\"><\/span><strong>Medplus Health Services Share Price Target 2028: Rs 1,000<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Medplus Health Services share price target 2028 is Rs 1,000, implying approximately 24 percent upside from CMP. By 2028, Medplus Health Services should have demonstrated through a full earnings cycle that the 16% growth assumption is sustainable, supporting a re-rating toward the Medplus Health Services share price target 2028 level at a forward multiple consistent with sector peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Medplus_Health_Services_Share_Price_Target_2030_Rs_1440\"><\/span><strong>Medplus Health Services Share Price Target 2030: Rs 1,440<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Medplus Health Services share price target 2030 is Rs 1,440, implying approximately 78 percent upside from CMP and a 4-year CAGR of approximately 16% from current levels. By 2030, Medplus Health Services should be a mature, well-understood franchise with a track record of consistent compounding that justifies the target multiple.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_for_the_Medplus_Health_Services_Share_Price_Target_2030\"><\/span><strong>Bull Case and Bear Case for the Medplus Health Services Share Price Target 2030<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Rs_1843\"><\/span><strong>Bull Case: Rs 1,843<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bull case Medplus Health Services share price target of Rs 1,843 by 2030: Rs 1,800 by 2030, if Medplus successfully replicates its South India cluster model in Maharashtra and NCR, and own-brand generic penetration reaches 30 percent of revenue, significantly expanding EBITDA margins.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Rs_1094\"><\/span><strong>Bear Case: Rs 1,094<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bear case Medplus Health Services share price target of Rs 1,094 by 2030: Rs 1,050 by 2030, if North India expansion costs exceed projections, competition from Reliance Retail Pharma intensifies pricing, and own-brand generic penetration stays below 15 percent.<\/p>\n<table style=\"border-collapse: collapse; width: 100%; margin: 16px 0;\">\n<tbody>\n<tr style=\"background: #1F4E79; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; border: 1px solid #ddd;\">Scenario<\/th>\n<th style=\"padding: 8px 12px; text-align: left; border: 1px solid #ddd;\">Target by 2030<\/th>\n<th style=\"padding: 8px 12px; text-align: left; border: 1px solid #ddd;\">Return<\/th>\n<th style=\"padding: 8px 12px; text-align: left; border: 1px solid #ddd;\">Key Assumption<\/th>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Bull Case<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 1,843<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">+128%<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Upside scenario with favourable execution and sector conditions<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Base Case<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 1,440<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">+78%<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">16% EPS CAGR; peer-multiple sustained through FY31<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Bear Case<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 1,094<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">+36%<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Downside scenario with adverse execution or macro headwinds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Medplus_Health_Services_Share_Price_Target\"><\/span><strong>Key Risks to the Medplus Health Services Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"USFDA_Inspection_and_Compliance_Risk\"><\/span><strong>USFDA Inspection and Compliance Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any USFDA warning letter or import alert on Medplus Health Services&#8217;s manufacturing facilities would delay product launches and revenue recognition, directly reducing the earnings trajectory behind the Medplus Health Services share price target. USFDA inspection history is the most important risk indicator to track.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Currency_Risk_on_Export_Revenue\"><\/span><strong>Currency Risk on Export Revenue<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Medplus Health Services&#8217;s international revenue is primarily in US dollars and euros. Any significant INR appreciation against these currencies would reduce the INR value of reported revenues and EPS, compressing the Medplus Health Services share price target earnings assumptions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Pricing_Pressure_in_Regulated_Generic_Markets\"><\/span><strong>Pricing Pressure in Regulated Generic Markets<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the US and EU generic markets, pricing erosion from competition intensifies as multiple players receive approvals for the same molecule. Any acceleration in generic pricing erosion in Medplus Health Services&#8217;s key export products would compress the Medplus Health Services share price target revenue base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Clinical_Trial_and_Pipeline_Risk\"><\/span><strong>Clinical Trial and Pipeline Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any setback in Medplus Health Services&#8217;s clinical trial results or regulatory approvals for pipeline products would delay the revenue ramp from specialty or novel products embedded in the Medplus Health Services share price target 2028 and 2030 assumptions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Medplus_Health_Services\"><\/span><strong>How to Invest in Medplus Health Services<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use the Univest Screener to track Medplus Health Services&#8217;s key financial metrics including EPS growth, margin trends, and analyst upgrades or downgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker MEDPLUS. Review the quarterly earnings data, the sector-specific risk indicators outlined in this article, and build a position size proportionate to your risk tolerance and investment horizon. Monitor each quarter for the key variables most likely to move the Medplus Health Services share price target. Consult a SEBI-registered financial advisor before making any investment decision.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Use the Univest Screener to Track This Stock Live<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Medplus Health Services share price target of Rs 835 for 2027, Rs 1,000 for 2028, and Rs 1,440 for 2030 reflects 16% annual earnings compounding and a forward multiple consistent with Pharmacy Retail peers. The key drivers and risks are outlined above. MedPlus runs a hyper-clustered, largely South India store footprint. A large share of stores operate on a cluster model where proximity to each other. For investors with a 3 to 4 year horizon and a tolerance for Pharmacy Retail-specific risk, the current CMP of Rs 806.95 offers a starting point for building a position aligned to the Medplus Health Services share price target 2030 thesis. Always verify data at NSE and BSE before investing.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-portfolio\/id1479183301\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=in.univest.app\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Medplus Health Services share price live and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Medplus_Health_Services_Share_Price_Target_2027_2028_and_2030\"><\/span><strong>Frequently Asked Questions on Medplus Health Services Share Price Target 2027 2028 and 2030<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Medplus_Health_Services_share_price_target_for_2027\"><\/span><strong>What is the Medplus Health Services share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Medplus Health Services share price target for 2027 is Rs 835, representing approximately 3 percent upside from CMP Rs 806.95 as of August 2026. Please verify all data with the official NSE website before making any investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Medplus_Health_Services_share_price_target_for_2030\"><\/span><strong>What is the Medplus Health Services share price target for 2030?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Medplus Health Services share price target for 2030 is Rs 1,440, implying approximately 78 percent upside from CMP Rs 806.95. This is based on analyst estimates and is not a guaranteed return. Always verify current data at NSE India before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Medplus_Health_Services_a_good_long-term_investment\"><\/span><strong>Is Medplus Health Services a good long-term investment?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medplus Health Services has a defined analyst consensus that projects earnings compounding through FY31 based on sector-specific growth drivers outlined in this article. Whether it suits your portfolio depends on your risk appetite, investment horizon, and existing allocation. Consult a SEBI-registered financial advisor for personalised guidance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_most_investors_miss_about_Medplus_Health_Services\"><\/span><strong>What do most investors miss about Medplus Health Services?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> MedPlus runs a hyper-clustered, largely South-India store footprint (bulk of stores in Telangana\/AP\/Tamil Nadu\/Karnataka), so it carries real geographic concentration risk; a large share of stores are still in their loss-making maturation window, which suppresses blended margins &#8211; steady-state econo<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_bull_case_for_the_Medplus_Health_Services_share_price_target_2030\"><\/span><strong>What is the bull case for the Medplus Health Services share price target 2030?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The bull case Medplus Health Services share price target for 2030 is Rs 1,843. This requires better-than-base-case execution on the key growth drivers specific to Medplus Health Services&#8217;s sector, as described in this article. These are analyst projections, not guaranteed returns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_risks_to_the_Medplus_Health_Services_share_price_target\"><\/span><strong>What are the main risks to the Medplus Health Services share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The key risks to the Medplus Health Services share price target include sector-specific headwinds such as credit cycles (for financial companies), regulatory changes, competitive pressure, and macroeconomic slowdown. Please review the risks section of this article for a full breakdown of the four most material risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Medplus_Health_Servicess_52-week_high_and_low_share_price\"><\/span><strong>What is Medplus Health Services&#8217;s 52-week high and low share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of August 2026, Medplus Health Services&#8217;s 52-week high is approximately Rs 1,200 and the 52-week low is approximately Rs 680. The CMP of Rs 806.95 sits between these levels. Always verify the latest 52-week data at NSE India or BSE before making any investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_buy_Medplus_Health_Services_shares\"><\/span><strong>How can I buy Medplus Health Services shares?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy Medplus Health Services shares through any SEBI-registered broker by searching for the NSE ticker MEDPLUS. Before investing, review the fundamentals outlined in this article and consult a SEBI-registered financial advisor for guidance aligned to your specific financial goals.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medplus Health Services share price target 2027 is Rs 835 (+3%), 2028 is Rs 1,000, and 2030 is Rs 1,440 (+78%). Pharmacy Retail stock. Full long term analyst fo<\/p>\n","protected":false},"author":28,"featured_media":191081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3972],"class_list":["post-191082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-target"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["191081"],"_edit_lock":["1786099757:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["79"],"rank_math_title":["Medplus Health Services Share Price Target 2027 2028 and 2030"],"rank_math_description":["Medplus Health Services share price target 2027 is Rs 835 (+3%), 2028 is Rs 1,000, and 2030 is Rs 1,440 (+78%). Pharmacy Retail stock."],"rank_math_focus_keyword":["Medplus Health Services share price target"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["35115"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/medplus-health-services-share-price-target-2027-2028-2030-1.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/191082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=191082"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/191082\/revisions"}],"predecessor-version":[{"id":191592,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/191082\/revisions\/191592"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/191081"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=191082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=191082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=191082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}